Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfa
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1743-422X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfa ; volume:8 ; number:1 ; day:20 ; month:1 ; year:2011 ; pages:1-6 ; date:12.2011
Virology journal ; 8, Heft 1 (20.1.2011), 1-6, 12.2011
- Creator
-
Wang, Shaoyang
- Contributor
-
Huang, Dedong
Sun, Shunlai
Ma, Weimin
Zhen, Qin
SpringerLink (Online service)
- DOI
-
10.1186/1743-422X-8-28
- URN
-
urn:nbn:de:1111-201605015349
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Shaoyang
- Huang, Dedong
- Sun, Shunlai
- Ma, Weimin
- Zhen, Qin
- SpringerLink (Online service)
Other Objects (12)
Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2
Hepatitis-C-Therapie : Management psychiatrischer Nebenwirkungen von Interferon alfa
Morbus Behçet: Langzeitprognose nach Therapie mit Interferon alfa-2a
Recognition of interferon-inducible sites, promoters, and enhancers
AQP5-1364A/C polymorphism affects AQP5 promoter methylation
Zur Behandlung der Haarzell-Leukämie mit rekombinantem Interferon alfa-2b
Tratamento intracístico de craniofaringioma com interferon alfa: relato de caso
Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers
Auftreten neutralisierender anti-Interferon Antikörper bei der Behandlung der Haarzell-Leukämie mit rekombinantem humanem Interferon-alfa-2c
RHDV 3C protein antagonizes type I interferon signaling by cleaving interferon promoter stimulated 1 protein
An RBP4 promoter polymorphism increases risk of type 2 diabetes
Interaction between a serotonin transporter gene promoter region polymorphism and stress predicts depressive symptoms in Chinese adolescents: a multi-wave longitudinal study
Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2
Hepatitis-C-Therapie : Management psychiatrischer Nebenwirkungen von Interferon alfa
Morbus Behçet: Langzeitprognose nach Therapie mit Interferon alfa-2a
Recognition of interferon-inducible sites, promoters, and enhancers
AQP5-1364A/C polymorphism affects AQP5 promoter methylation
Zur Behandlung der Haarzell-Leukämie mit rekombinantem Interferon alfa-2b
Tratamento intracístico de craniofaringioma com interferon alfa: relato de caso
Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers
Auftreten neutralisierender anti-Interferon Antikörper bei der Behandlung der Haarzell-Leukämie mit rekombinantem humanem Interferon-alfa-2c
RHDV 3C protein antagonizes type I interferon signaling by cleaving interferon promoter stimulated 1 protein
An RBP4 promoter polymorphism increases risk of type 2 diabetes
Interaction between a serotonin transporter gene promoter region polymorphism and stress predicts depressive symptoms in Chinese adolescents: a multi-wave longitudinal study
Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2
Hepatitis-C-Therapie : Management psychiatrischer Nebenwirkungen von Interferon alfa
Morbus Behçet: Langzeitprognose nach Therapie mit Interferon alfa-2a
Recognition of interferon-inducible sites, promoters, and enhancers
AQP5-1364A/C polymorphism affects AQP5 promoter methylation
Zur Behandlung der Haarzell-Leukämie mit rekombinantem Interferon alfa-2b
Tratamento intracístico de craniofaringioma com interferon alfa: relato de caso
Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers
Auftreten neutralisierender anti-Interferon Antikörper bei der Behandlung der Haarzell-Leukämie mit rekombinantem humanem Interferon-alfa-2c
RHDV 3C protein antagonizes type I interferon signaling by cleaving interferon promoter stimulated 1 protein
An RBP4 promoter polymorphism increases risk of type 2 diabetes